Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00186030 · ClinicalTrials.gov registry record · Phase 1
Reducing Risk and Trauma-Related Stress in Persons Living With HIV
A Phase 1 study, sponsored by Stanford University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 102
- Enrollment target
NCT00186030: Clinical Trial Phase 1 study, sponsored by Stanford University.
NCT00186030 is a Phase 1 study that was terminated before completion, run by Stanford University. The registered enrollment target is 102 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00186030, a Phase 1 study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 102 participants
- Enrollment target
Study Summary
This two-year study tested the concept that an intervention, which reduces trauma-related symptoms among adults who are living with human immunodeficiency virus (HIV), are experiencing trauma-related stress symptoms, and engaging in behavior that facilitates HIV transmission, can reduce the transmission risk of (HIV). Our central premise was that by first treating trauma symptoms, we would enhance the effects of a skills-building HIV risk reduction intervention for adults experiencing trauma-related symptoms such as hyperarousal, dissociation, and avoidance. The study aims were to: 1. To determine if decreasing trauma-related stress symptoms improves HIV risk reduction behavior above a standard HIV risk reduction intervention alone post-intervention and 3 months after the small group intervention sessions; 2. To determine whether key variables moderate the intervention's effects. For instance, gender, age, ethnicity, or psychological distress (e.g., depression, anxiety) may interact with the intervention to affect risky sexual or drug-related behavior; and 3. To determine whether there is evidence that the theoretical mediator variables, which include trauma-related stress symptoms, self-efficacy, communication skills, and social support mediate the intervention's effects on outcomes. This information addresses the theoretical question of why the intervention works.
Interventions
- BEHAVIORAL HIV Skills-based Prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2003-04 |
| Est. Completion | 2004-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00186030
The ClinicalTrials.gov registry entry for NCT00186030 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HIV Skills-based Prevention is the first listed.
NCT00186030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00186030 about?
NCT00186030 is a clinical study titled "Reducing Risk and Trauma-Related Stress in Persons Living With HIV". This two-year study tested the concept that an intervention, which reduces trauma-related symptoms among adults who are living with human immunodeficiency virus (HIV), are experiencing trauma-related stress symptoms, and engaging in behavior that facilitates HIV transmission, can reduce the transmis...
What is the current status of trial NCT00186030?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 102 participants. The study started on 2003-04. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00186030?
The interventions under investigation include: HIV Skills-based Prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00186030?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.